Meningococcal serogroup B vaccines: Estimating breadth of coverage

Neisseria meningitidis serogroup B (MenB) is an important cause of invasive meningococcal disease. The development of safe and effective vaccines with activity across the diversity of MenB strains has been challenging. While capsular polysaccharide conjugate vaccines have been highly successful in t...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Hum Vaccin Immunother
Auteurs principaux: Donald, Robert G. K., Hawkins, Julio Cesar, Hao, Li, Liberator, Paul, Jones, Thomas R., Harris, Shannon L., Perez, John L., Eiden, Joseph J., Jansen, Kathrin U., Anderson, Annaliesa S.
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2016
Sujets:
Review
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5328210/
https://ncbi.nlm.nih.gov/pubmed/27960595
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1264750
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires